RestorixHealth, AMT Unite Under New Corporate Branding

METAIRIE, La.–(BUSINESS WIRE)–RestorixHealth, the nation’s leading wound care solutions company, is pleased to announce that American Medical Technologies (AMT) and RestorixHealth have completed an extensive rebrand and will unite under the RestorixHealth name.


Since RestorixHealth and AMT’s merger in 2021, the companies have had the opportunity to incorporate their strengths and expertise to broaden their reach across the care continuum. Together, they manage 260 wound centers across 36 states, serve more than 6,000 post-acute facilities across all 50 states and contract with more than 2,400 payers.

Bringing the two companies together under one name reinforces their unified position and reputation as leaders in the wound care industry dedicated to advancing their mission to restore health and improve the quality of life – and access to care – for patients with wounds.

The brand name, RestorixHealth, is rooted in the company’s commitment to restoring health and best reflected the company’s values and commitment to excellence in wound care. In addition, the RestorixHealth At-Home Wound Healing Services and At-Home Wound Care Supplies service lines will join AMT under the RestorixHealth name.

About RestorixHealth

Committed to excellence in wound care, RestorixHealth is the wound care solutions company providing programs, services, products and education across the care continuum. From developing and operating wound centers in partnership with hospitals, through supporting long-term care facilities with education and supplies, to providing in-home care, RestorixHealth’s solutions increase access to care, reduce hospital admissions, lower or avoid direct care costs and most importantly, improve patient outcomes and quality of life. For more information, visit www.RestorixHealth.com.

Contacts

Leah Paternostro

Communications Coordinator

(985) 445-5512

[email protected]

Jill Garretson

VP, Marketing

(914) 425-5884

[email protected]

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Businesswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, businesswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Subscribe to receive exclusive content and notifications to your inbox

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.